Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma

Histopathology

Volumn 57, Issue 1, 2010, Pages 90-100

  Sonoda, Ryotaro ^a   Naomoto, Yoshio ^a   Shirakawa, Yasuhiro ^a   Fujiwara, Yasuhiro ^a   Yamatsuji, Tomoki ^a   Noma, Kazuhiro ^a   Tanabe, Shunsuke ^a   Takaoka, Munenori ^a   Gunduz, Mehmet ^b   Tsujigiwa, Hidetsugu ^b   Nagatsuka, Hitoshi ^b   Ohara, Nobuya ^b   Yoshino, Tadashi ^b   Takubo, Kaiyo ^c   Vieth, Michael ^d   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Barrett's oesophagus; cyclooxygenase 2; heparanase; intestinal type gastric carcinoma

Indexed keywords

CYCLOOXYGENASE 2; HEPARANASE; MESSENGER RNA; BETA GLUCURONIDASE; PRIMER DNA; RNA;

ARTICLE; BARRETT ESOPHAGUS; CANCER CELL CULTURE; CARCINOGENESIS; CHRONIC INFLAMMATION; DYSPLASIA; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; METAPLASIA; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; ADENOCARCINOMA; CARCINOMA IN SITU; ENZYMOLOGY; ESOPHAGUS TUMOR; GENETICS; METABOLISM; MICROVASCULATURE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION; VASCULARIZATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BASE SEQUENCE; CARCINOMA IN SITU; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; GLUCURONIDASE; HUMANS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; UP-REGULATION;

EID: 77954562497     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03594.x     Document Type: Article

References (52)

1. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999 340 825 831.
2. Stein HJ, Siewert JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia 1993 8 276 288.
3. Spechler SJ, Goyal RK. Barrett's esophagus. N. Engl. J. Med. 1986 315 362 371.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 52 6735 6740.
5. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 1965 64 31 49.
6. Makola D, Peura DA, Crowe SE. Helicobacter pylori infection and related gastrointestinal diseases. J. Clin. Gastroenterol. 2007 41 548 558.
7. Vlodavsky I, Goldshmidt O, Zcharia E et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin. Cancer Biol. 2002 12 121 129.
8. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 2001 108 341 347. (Pubitemid 32730777)
9. Zcharia E, Zilka R, Yaar A et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J. 2005 19 211 221.
10. Gohji K, Okamoto M, Kitazawa S et al. Heparanase protein and gene expression in bladder cancer. J. Urol. 2001 166 1286 1290.
11. Friedmann Y, Vlodavsky I, Aingorn H et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am. J. Pathol. 2000 157 1167 1175.
12. Tang W, Nakamura Y, Tsujimoto M et al. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod. Pathol. 2002 15 593 598.
13. Maxhimer JB, Quiros RM, Stewart R et al. Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery 2002 132 326 333.
14. Mikami S, Ohashi K, Usui Y et al. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn. J. Cancer Res. 2001 92 1062 1073.
15. Koliopanos A, Friess H, Kleeff J et al. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 2001 61 4655 4659. (Pubitemid 32691870)
16. Okawa T, Naomoto Y, Nobuhisa T et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin. Cancer Res. 2005 11 7995 8005.
17. Imada T, Matsuoka J, Nobuhisa T et al. COX-2 induction by heparanase in the progression of breast cancer. Int. J. Mol. Med. 2006 17 221 228.
18. Ohtawa Y, Naomoto Y, Shirakawa Y et al. The close relationship between heparanase and cyclooxygenase-2 expressions in signet-ring cell carcinoma of the stomach. Hum. Pathol. 2006 37 1145 1152.
19. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999 18 7908 7916.
20. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995 83 493 501.
21. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA 1997 94 3336 3340.
22. Prescott SM, White RL. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 1996 87 783 786.
23. Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am. J. Gastroenterol. 2001 96 990 996.
24. Lagorce C, Paraf F, Vidaud D et al. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopathology 2003 42 457 465.
25. Japan Esophageal Society. Japanese classification of esophageal cancer, 10th edn.
26. Flejou JF, Svrcek M. Barrett's oesophagus - a pathologist's view. Histopathology 2007 50 3 14.
27. Takubo K, Aida J, Naomoto Y et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum. Pathol. 2009 40 65 74.
28. Toyoshima M, Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J. Biol. Chem. 1999 274 24153 24160.
29. Takaoka M, Naomoto Y, Ohkawa T et al. Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab. Invest. 2003 83 613 622.
30. Flejou JF. Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 2005 54 6 12.
31. Maley CC, Rustgi AK. Barrett's esophagus and its progression to adenocarcinoma. J. Natl. Compr. Canc. Netw. 2006 4 367 374.
32. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998 58 2929 2934.
33. Kandil HM, Tanner G, Smalley W, Halter S, Radhika A, Dubois RN. Cyclooxygenase-2 expression in Barrett's esophagus. Dig. Dis. Sci. 2001 46 785 789.
34. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999 59 198 204.
35. Vlodavsky I, Eldor A, Haimovitz-Friedman A et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992 12 112 127.
36. Dubois RN, Abramson SB, Crofford L et al. Cyclooxygenase in biology and disease. FASEB J. 1998 12 1063 1073.
37. Jiang P, Kumar A, Parrillo JE et al. Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J. Biol. Chem. 2002 277 8989 8998.
38. Lu WC, Liu YN, Kang BB, Chen JH. Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 2003 22 919 923.
39. Maxhimer JB, Somenek M, Rao G et al. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 2005 54 2172 2178.
40. Shteper PJ, Zcharia E, Ashhab Y, Peretz T, Vlodavsky I, Ben-Yehuda D. Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene 2003 22 7737 7749.
41. Ogishima T, Shiina H, Breault JE et al. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin. Cancer Res. 2005 11 1028 1036.
42. Ogishima T, Shiina H, Breault JE et al. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 2005 24 6765 6772.
43. Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I. Tumor suppressor p53 regulates heparanase gene expression. Oncogene 2006 25 3939 3947.
44. Jenkins GJ, Doak SH, Griffiths AP et al. Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology. Br. J. Cancer 2003 88 1271 1276.
45. Wang Z, Zhang X, Xu H, Zhou X, Jiang Z, Lu C. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples. J. Surg. Oncol. 2005 90 59 65.
46. Wang Z, Xu H, Jiang L, Zhou X, Lu C, Zhang X. Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma. Mod. Pathol. 2005 18 205 211. (Pubitemid 40188627)
47. Endo K, Maejara U, Baba H et al. Heparanase gene expression and metastatic potential in human gastric cancer. Anticancer Res. 2001 21 3365 3369.
48. Woude CJ, Kleibeuker JH, Tiebosch AT et al. Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins. J. Clin. Pathol. 2003 56 699 702.
49. Saukkonen K, Nieminen O, van Rees B et al. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin. Cancer Res. 2001 7 1923 1931.
50. Joo YE, Oh WT, Rew JS, Park CS, Choi SK, Kim SJ. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion 2002 66 222 229.
51. Yamagata R, Shimoyama T, Fukuda S, Yoshimura T, Tanaka M, Munakata A. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur. J. Gastroenterol. Hepatol. 2002 14 347 349.
52. Honjo S, Kase S, Osaki M, Ardyanto TD, Kaibara N, Ito H. Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index. Anticancer Res. 2004 24 1439 1444.